* Fiscal year 2019
GAAP revenue of $4,731 billion and non-GAAP revenue of $4,762 billion
* First quarter fiscal 2020 total company non-GAAP revenue of $267 million, or 23% growth year-over-year; total company
GAAP revenue of $247 million, or 16% growth year-over-year
* Fiscal year 2019
GAAP operating margin expansion of 110 basis points year-over-year.
*
GAAP net loss was $11.4 million, or $0.57 per basic share, compared with net income of $8.0 million, or $0.40 per diluted share in the second quarter of 2018, and a net loss of $10.5 million, or $0.53 per basic share in the first quarter of 2019.
Healthcare company PerkinElmer Inc (NYSE:PKI) disclosed on Monday its
GAAP earnings per share from continuing operations of USD0.62 for the second quarter ended 30 June 2019.
As the reporting of non-GAAP financial performance measures has gained popularity, these measures have raised concerns at the SEC as to whether they are more prominent than
GAAP measures or misleading to investors.
GAAP Operating Income was up 1% to $2.8 billion and
GAAP Operating Margin was 30%.
This marks a growth when compared with
GAAP net income of USD0.8m (USD0.02 per diluted share) for the second quarter of 2017 and
GAAP net income of USD2.0m (USD0.05 per diluted share) for the third quarter of 2016, respectively.
Gross profit: USD99.2 million
GAAP compared to USD87.4 million in the third quarter of 2015.
In any accounting period, a company's net income as determined while applying
GAAP might include certain one-time expenses that management believes might actually distort that period's earnings picture.
GAAP diluted net loss per share was USD0.01 for the first quarter of 2016, compared with USD0.01 for the first quarter of 2015.
